本公司董事会及董事保证公募产品季度报告所载资料不存在虚假记载、误导性陈述或重大遗漏，并对其 内容的真实性、准确性和完整性承担个别及连带责任。 兴证证券资产管理有限公司旗下： 1.兴证资管国企红利优选混合型发起式证券投资基金 2.兴证资管金麒麟领先优势一年持有期混合型证券投资基金 3.兴证资管金麒麟消费升级混合型证券投资基金 4.兴证资管金麒麟恒睿致远一年持有期混合型证券投资基金 9.兴证资管金麒麟兴享优选一年持有期混合型集合资产管理计划 10.兴证资管金麒麟兴睿优选一年持有期混合型集合资产管理计划 11.兴证资管金麒麟兴享增利六个月持有期债券型集合资产管理计划 上述公募产品的2025年第3季度报告全文于2025年10月28日在本公司网站[http://www.ixzzcgl.com]和中国 证监会基金电子披露网站（http://eid.csrc.gov.cn/fund）披露，供投资者查阅。如有疑问可拨打本公司客 服电话（95562-3）咨询。 本管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证基金一定盈利，也不保证最 低收益。请充分了解基金的风险收益特征，审慎做出投资决定。 特此公告。 兴证证 ...

Core Insights - The article highlights the impressive performance of the "Xingzheng Asset Management Golden Qilin Xingxiang Preferred One-Year Holding Period Mixed Asset Management Plan," which achieved a net value growth rate of 107.91% over the past year and 78.36% year-to-date, significantly outperforming similar products in the market [1][2][3] - The success is attributed to the investment manager Zheng Fangbiao, who combines a strong educational background with extensive experience in investment research, emphasizing a disciplined and patient investment approach [1][2] Investment Strategy - Zheng Fangbiao's investment philosophy is influenced by his background in Go, where strategic thinking and patience are crucial, paralleling the need for a comprehensive understanding of both micro and macroeconomic factors in investing [2][3] - The focus on the technology sector as a core investment direction was established early in 2023, despite market volatility and skepticism from other investors [2][3] Portfolio Composition - The top ten holdings of the fund reflect a strong emphasis on technology and innovation, including companies like Xinyi Technology, Zhongji Xuchuang, and Cambrian [3][4] - The inclusion of Pop Mart in the top holdings demonstrates a strategic bet on the new consumption trend, showcasing the manager's ability to identify long-term value in emerging sectors [4] Future Outlook - For the second half of 2025, three key investment directions are highlighted: opportunities arising from the AI revolution, high-end manufacturing and innovative pharmaceuticals, and undervalued companies with high dividends [5] - The emphasis on AI as a transformative force in the economy suggests a long-term bullish outlook on technology investments, positioning them as the main battleground for growth stocks [5] Performance Metrics - Historical performance data indicates that the fund has faced challenges in previous years, with negative returns in 2022 and 2023, but has shown a significant turnaround in 2024 [7] - The fund's performance is benchmarked against the CSI 300 Index and the China Bond Composite Index, providing a comparative framework for evaluating its success [7]